129 related articles for article (PubMed ID: 9516852)
1. Expression and function of Trk-C in favourable human neuroblastomas.
Yamashiro DJ; Liu XG; Lee CP; Nakagawara A; Ikegaki N; McGregor LM; Baylin SB; Brodeur GM
Eur J Cancer; 1997 Oct; 33(12):2054-7. PubMed ID: 9516852
[TBL] [Abstract][Full Text] [Related]
2. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
Eur J Cancer; 1997 Oct; 33(12):2058-63. PubMed ID: 9580079
[TBL] [Abstract][Full Text] [Related]
3. Expression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara A; Azar CG; Scavarda NJ; Brodeur GM
Mol Cell Biol; 1994 Jan; 14(1):759-67. PubMed ID: 8264643
[TBL] [Abstract][Full Text] [Related]
4. Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study.
Nakagawara A; Brodeur GM
Eur J Cancer; 1997 Oct; 33(12):2050-3. PubMed ID: 9516851
[TBL] [Abstract][Full Text] [Related]
5. Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis.
Rydén M; Sehgal R; Dominici C; Schilling FH; Ibáñez CF; Kogner P
Br J Cancer; 1996 Sep; 74(5):773-9. PubMed ID: 8795581
[TBL] [Abstract][Full Text] [Related]
6. Correlation of MYCN amplification, Trk-A and CD44 expression with clinical stage in 250 patients with neuroblastoma.
Kramer K; Cheung NK; Gerald WL; LaQuaglia M; Kushner BH; LeClerc JM; LeSauter L; Saragovi HU
Eur J Cancer; 1997 Oct; 33(12):2098-100. PubMed ID: 9516861
[TBL] [Abstract][Full Text] [Related]
7. Expression of TrkC in favorable human neuroblastomas.
Yamashiro DJ; Nakagawara A; Ikegaki N; Liu XG; Brodeur GM
Oncogene; 1996 Jan; 12(1):37-41. PubMed ID: 8552397
[TBL] [Abstract][Full Text] [Related]
8. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N
Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212
[TBL] [Abstract][Full Text] [Related]
9. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
10. Expression of the nerve growth factor receptor c-TRK in human myeloid leukaemia cells.
Kaebisch A; Brokt S; Seay U; Lohmeyer J; Jaeger U; Pralle H
Br J Haematol; 1996 Oct; 95(1):102-9. PubMed ID: 8857945
[TBL] [Abstract][Full Text] [Related]
11. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
Azar CG; Scavarda NJ; Nakagawara A; Brodeur GM
Prog Clin Biol Res; 1994; 385():169-75. PubMed ID: 7972209
[TBL] [Abstract][Full Text] [Related]
12. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2.
Hishiki T; Nimura Y; Isogai E; Kondo K; Ichimiya S; Nakamura Y; Ozaki T; Sakiyama S; Hirose M; Seki N; Takahashi H; Ohnuma N; Tanabe M; Nakagawara A
Cancer Res; 1998 May; 58(10):2158-65. PubMed ID: 9605760
[TBL] [Abstract][Full Text] [Related]
13. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
14. High affinity nerve growth factor receptor expression (gp140trkA), N-myc amplification, histopathology, and survival in neuroblastoma.
Miyake M; Suzuki T; Shimada H; Stram D; Seeger RC
Prog Clin Biol Res; 1994; 385():163-8. PubMed ID: 7972208
[No Abstract] [Full Text] [Related]
15. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S
Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728
[TBL] [Abstract][Full Text] [Related]
16. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
[TBL] [Abstract][Full Text] [Related]
17. Inverse relationship between trk expression and N-myc amplification in human neuroblastomas.
Nakagawara A; Arima M; Azar CG; Scavarda NJ; Brodeur GM
Cancer Res; 1992 Mar; 52(5):1364-8. PubMed ID: 1737399
[TBL] [Abstract][Full Text] [Related]
18. Abundant but inactive-state gp140proto-trk is expressed in neuroblastomas of patients with good prognosis.
Iwata H; Ito T; Mutoh T; Ishiguro Y; Xiao H; Hamaguchi M
Jpn J Cancer Res; 1994 Jan; 85(1):32-9. PubMed ID: 7508904
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of phosphorylation of TrkB and TrkC and their signal transduction by alpha2-macroglobulin.
Hu YQ; Koo PH
J Neurochem; 1998 Jul; 71(1):213-20. PubMed ID: 9648868
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of pleiotrophin and midkine in advanced neuroblastomas.
Nakagawara A; Milbrandt J; Muramatsu T; Deuel TF; Zhao H; Cnaan A; Brodeur GM
Cancer Res; 1995 Apr; 55(8):1792-7. PubMed ID: 7712489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
